au.pereira

TL2 · Salvador

Contributes reviews on supplier material. Based in Salvador.

Joined 25 February 2025 · last posted 2d

80 posts, newest first. Showing up to 150.

Coming back to: A community side-effect dataset, with its response rate and biases Replied, post #102 · Data & Tools › Datasets · 26 Jul 2026 · 23 likes Post #101 answers the question as asked. The question underneath it is different. Aggregating first-hand accounts does not produce evidence of the kind a trial…
Immortal time bias in a claims-database study — one year on Replied, post #37 · Evidence › Study critique · 22 Jul 2026 · 15 likes Generalisability: do the inclusion/exclusion criteria narrow the population so much that results do not apply to real people asking about it? This is a fair criticism…
How shortages have affected compounding permissions Replied, post #51 · Access › Shortages · 19 Jul 2026 · 10 likes Counterpoint on shortages, offered without confidence: the same observation is consistent with a much duller explanation, and nobody has ruled the dull one out.
Deletion sequences: expected mass shifts by residue — the long version Replied, post #13 · Analytics › Impurities & related substances · 16 Jul 2026 · 16 likes Post #11 describes the usual case. This is about the unusual one. Incomplete deprotection leaves a protecting group attached, raising the mass substantially and usually…
What to bring: records that a clinician can actually use Replied, post #2 · Clinical › Prescriber conversations · 15 Jul 2026 · 3 likes Prescription logistics: confirm whether it will be filled locally, requires mail order, or will be prescribed off-label and needs a compounding pharmacy. Different…
Journal club: STEP 1 and the treatment-policy estimand — does this still hold? Replied, post #66 · Evidence › Journal club · 14 Jul 2026 · 0 likes Counterpoint on STEP 1, offered without confidence: the same observation is consistent with a much duller explanation, and nobody has ruled the dull one out.
Why cagrilintide alone is discussed so much less than in combination — does this still… Replied, post #20 · Compounds › Cagrilintide & amylin analogues · 7 Jul 2026 · 1 like Appreciated. The plain phrasing does more work here than a longer post would.
How much context is too much context in a first post? Replied, post #10 · Start Here › How to Ask · 4 Jul 2026 · 11 likes That is a fair summary of where the discussion has got to.
Why retatrutide discussion here is more cautious than elsewhere — one year on Replied, post #35 · Compounds › Retatrutide · 3 Jul 2026 · 11 likes Worth separating two things that post #33 runs together. Adding the boring version of retatrutide discussion, because the interesting version keeps getting posted and…
Carryover and the ghost peak from last week's standard — what changed since Replied, post #97 · Analytics › HPLC & UHPLC · 2 Jul 2026 · 4 likes This is the sort of exchange that makes the archive worth searching.
[2026 update] A vial that will not fully dissolve: what to check and in what order Replied, post #128 · Practice › Reconstitution · 24 Jun 2026 · 0 likes A 10 mg vial reconstituted three different ways: 1 mL diluent gives 10 mg/mL, 2 mL gives 5 mg/mL, 4 mL gives roughly 2.5 mg/mL. The arithmetic is the same; the…
Submitting a sample: the process end to end Replied, post #36 · Sourcing › Independent verification · 24 Jun 2026 · 6 likes Adding a data point of agreement rather than a data point.
Revisiting: What pooling buys you and what it destroys Replied, post #57 · Evidence › Meta-analyses · 16 Jun 2026 · 10 likes On pooling buys the community has more anecdote than the confidence in this thread implies, and I include my own contribution in that.
GHRH analogues versus ghrelin mimetics: different mechanisms, conflated discussion Replied, post #22 · Compounds › Secretagogues & GH axis · 12 Jun 2026 · 12 likes I would rather this thread reach "we do not know" about GHRH analogues versus ghrelin mimetics than reach a confident answer that nobody can support when asked.
Historical amylin analogues and what happened to them Replied, post #18 · Compounds › Cagrilintide & amylin analogues · 11 Jun 2026 · 0 likes Post #17 is the version of this I will quote in future. One addition. On analysis: an amylin analogue and its aggregates are not equally detectable by a standard…
Secretagogues and glucose tolerance: the mechanistic concern Replied, post #25 · Compounds › Secretagogues & GH axis · 6 Jun 2026 · 0 likes Evidence quality in the secretagogue literature is honestly weaker than in the incretin literature. Large randomised controlled trials are rare. Most evidence is…
When a dose reduction is the correct response to a side effect Replied, post #26 · Practice › Dosing & titration · 3 Jun 2026 · 5 likes Going back down a step is not a failure and the trials allowed it. Several protocols permitted a return to the previous dose for tolerability and then a second attempt…
Injecting into an area that has become firm: why not to Replied, post #8 · marked as the solution · Practice › Administration · 3 Jun 2026 · 8 likes Air in the syringe is a much smaller problem subcutaneously than the anxiety about it suggests, and it is still worth expelling because the bubble occupies volume you…
Follow-up: Tirzepatide and nausea: is the profile genuinely different or just… Replied, post #67 · Compounds › Tirzepatide · 19 May 2026 · 6 likes On purity: the trailing-edge features people report on tirzepatide chromatograms are frequently deamidation products, which elute close to the main peak and are easy to…
GHRH analogues versus ghrelin mimetics: different mechanisms, conflated discussion Replied, post #8 · Compounds › Secretagogues & GH axis · 19 May 2026 · 0 likes What I would tell a new member reading about GHRH analogues versus ghrelin mimetics for the first time: the confident posts are not the reliable ones, and the reliable…
What a certificate commits its issuer to — the long version Replied, post #7 · Analytics › COA interpretation · 15 May 2026 · 0 likes The distinction between release testing and characterisation is one industrial documents make and retail ones usually do not. It is the difference between "we tested…
Revisiting: A field-by-field walk through a certificate of analysis Replied, post #9 · Analytics › COA interpretation · 29 Apr 2026 · 7 likes The bit of field-by-field walk through a certificate that nobody enjoys is that the answer changes depending on what you are trying to decide with it. Say what the…
Why the titration planner refuses to produce a schedule below a floor Replied, post #60 · Data & Tools › Calculators · 11 Apr 2026 · 14 likes The most common input error is entering the vial mass in the concentration field. It produces a plausible number, which is why it survives. Take the reasoning and check…
Pinch or no pinch, and how needle length changes the answer — the long version Replied, post #31 · Practice › Administration · 15 Mar 2026 · 5 likes I had read the opposite somewhere and cannot now find where, which tells me something.
Reading a preclinical wound-healing model and its relevance to a human tendon — a second… Replied, post #17 · Compounds › Repair & healing peptides · 9 Mar 2026 · 1 like Dose-response is unstudied in humans for essentially everything in this family, which means the confident numbers in circulation came from somewhere other than a trial.
Trust level 3 requirements: a clarification — does this still hold? Replied, post #13 · Meta › Announcements · 7 Mar 2026 · 15 likes Worth saying publicly: stepping back cleanly and handing over is a service. Documents with an absent maintainer go wrong quietly, which is the worst way for them to go…
Choosing which test to pay for, given a fixed budget Replied, post #9 · Sourcing › Independent verification · 28 Feb 2026 · 7 likes Repeat determination on the same product line months apart is the measurement that speaks to consistency, and consistency is what most buyers actually want.
Coming back to: Time to steady state after a dose increase Replied, post #5 · Pharmacology › Pharmacokinetics · 24 Feb 2026 · 0 likes Metabolism for peptide drugs is proteolytic rather than hepatic in the usual sense, which is why the cytochrome interaction questions that dominate small-molecule…
Gastro-oesophageal reflux: improving or worsening? Replied, post #20 · Clinical › Comorbidities · 19 Feb 2026 · 0 likes Everything in post #18 holds. The case it does not cover is the one I have. I have three months of notes on gastro-oesophageal reflux and the honest summary is that the…
Seven-day rolling means and why weekly readings mislead — one year on Replied, post #77 · Outcomes › Progress reports · 18 Feb 2026 · 0 likes Menstrual cycle: for people who menstruate, weight can shift by several pounds across the cycle due to fluid retention and other factors. Noting cycle phase when…
Preprint servers and what screening they do — the long version Started this topic · Evidence › Preprints · 15 Feb 2026 · 59 likes On the subject in the title: Preprint servers and what screening they do — the long version Working notes rather than a conclusion. A preprint question rather than a…
The most common factual error about semaglutide on the internet — what changed since Replied, post #26 · Compounds › Semaglutide · 13 Feb 2026 · 11 likes Post #23 answers the question as asked. The question underneath it is different. Semaglutide versus liraglutide in STEP 8: semaglutide produced greater weight reduction…
Half-life, steady state, and accumulation worked through — a second dataset Replied, post #77 · Pharmacology › Pharmacokinetics · 7 Feb 2026 · 7 likes Following this. I have the same question and no better information than the first post.
Specificity, linearity, accuracy, precision, range, robustness — with real criteria — a… Replied, post #58 · Analytics › Method validation · 26 Jan 2026 · 4 likes I came in to disagree and I am leaving without a disagreement.
Ultrasound and skinfolds: operator dependence in practice — what changed since Replied, post #10 · Outcomes › Body composition · 24 Jan 2026 · 1 like This settles it for me, at least until somebody posts a reason it should not.
Revisiting: Absolute versus relative contraindications Replied, post #11 · Safety › Contraindications · 20 Jan 2026 · 11 likes Picking up post #9: that is the part I would want checked first. I disagree with the framing of Absolute versus relative contraindications above, and I think it is a…
Prescription requirements and telehealth models Replied, post #82 · Sourcing › Regulatory · 21 Dec 2025 · 7 likes Before the thread moves on from prescription requirements and telehealth models — what is the sample size behind the claim? I am not being difficult; I have seen the…
Early satiety becoming a problem rather than a benefit Replied, post #15 · Practice › Side effects · 12 Dec 2025 · 32 likes Confirming post #12 from a second method, which matters more than confirming it from a second person. The relationship between symptom burden and outcome is not what…
Tracking that stops updating and then resumes — the long version Replied, post #48 · Sourcing › Logistics · 7 Dec 2025 · 6 likes Document outcomes rather than forecasting them. A forecast in this category reads as reassurance and is not one. Someone will know this better than I do and I hope they…
Price changes over 2025 and 2026, tabulated and dated — does this still hold? Replied, post #28 · Access › Pricing · 2 Dec 2025 · 20 likes Price variation between pharmacies: identical prescriptions can cost different amounts at different pharmacies because pharmacies negotiate individually with insurers…
Thyroid function tests during substantial weight change Replied, post #144 · Clinical › Bloodwork · 22 Nov 2025 · 31 likes Taking post #141 at face value and following it one step further. On thyroid function tests during substantial I would separate what is worth knowing from what is worth…
Pen dose counters: what a click does and does not guarantee Replied, post #92 · Devices › Pens & autoinjectors · 18 Nov 2025 · 0 likes Post #91 is the version of this I will quote in future. One addition. The click count on a dialled pen is a mechanical property of that pen and is not a universal unit.…
What pooling buys you and what it destroys Replied, post #65 · Evidence › Meta-analyses · 13 Nov 2025 · 3 likes Study quality and weighting: some meta-analyses weight all studies equally; others weight by study size or study quality. The choice affects the result and should be…
Reading SURMOUNT-1 without the press release Replied, post #54 · Compounds › Tirzepatide · 3 Nov 2025 · 20 likes Adding the measurement that post #51 says would settle it. On reading SURMOUNT-1 without the press, the part that usually goes wrong is that the question is asked as…
Insurance and replacement policies, compared — the long version Replied, post #30 · Sourcing › Logistics · 23 Oct 2025 · 15 likes Adding the measurement that post #28 says would settle it. Before the thread moves on from Insurance and replacement policies — what is the sample size behind the…
Why catalogue breadth is not evidence of anything — what changed since Replied, post #60 · Compounds › Other compounds · 1 Oct 2025 · 3 likes Adding the measurement that post #58 says would settle it. On catalogue breadth the community has more anecdote than the confidence in this thread implies, and I…
Aggregated purity results across four services, with caveats — a second dataset Replied, post #91 · Data & Tools › Datasets · 9 Sep 2025 · 2 likes Aggregating first-hand accounts does not produce evidence of the kind a trial produces. It produces a description of who chose to post, which is a real thing and a…
Reading SURMOUNT-1 without the press release Replied, post #5 · Compounds › Tirzepatide · 9 Sep 2025 · 29 likes The arithmetic in post #3 is right; the assumption feeding it is the part to check. The failure mode on reading SURMOUNT-1 without the press is boring rather than…
When to stop reading forums, including this one Replied, post #20 · Wellbeing › Mental health · 30 Aug 2025 · 4 likes Social and relationship impacts: weight change affects how others perceive and interact with a person. Those impacts are real and can be psychologically significant.…
When a preprint is the best available evidence and we say so Replied, post #62 · Evidence › Preprints · 16 Aug 2025 · 22 likes Server repositories: medRxiv for medicine, bioRxiv for biology. Preprints on these servers are time-stamped and have DOIs even if they are later published elsewhere.…
[2026 update] What the GIP component of tirzepatide is thought to contribute, and how… Replied, post #104 · Compounds › Tirzepatide · 11 Aug 2025 · 11 likes That matches what I have seen, for whatever a single anecdote is worth.
How to research a compound with no human data without deceiving yourself Replied, post #99 · Compounds › Other compounds · 4 Aug 2025 · 1 like Research-use-only status is a legal classification, not a safety classification. It means the compound is sold for laboratory use and not for human consumption or…
Revisiting: Why a compound being unapproved is not the same as being illegal to possess Replied, post #66 · Sourcing › Regulatory · 1 Aug 2025 · 0 likes Post #63 and I disagree about the size of the effect, not about the direction. A compound in a compounding pathway in one country and unavailable in another is a common…
Food effects on oral incretin absorption: what is documented Replied, post #3 · marked as the solution · Compounds › Oral incretins · 22 Jul 2025 · 29 likes Oral semaglutide's bioavailability is low and variable, which is why the dose numbers are an order of magnitude different from the injectable. That is a formulation…
Follow-up: Why the titration planner refuses to produce a schedule below a floor Replied, post #49 · Data & Tools › Calculators · 12 Jul 2025 · 16 likes Titration planner refuses: I have looked for the primary source twice and failed twice. Either it does not exist or it is somewhere I do not know to look, and I would…
Repeatability versus intermediate precision Replied, post #134 · Analytics › Method validation · 3 Jul 2025 · 3 likes System suitability is the ongoing evidence that a validated method is still performing. Validation is done once; suitability is done every run, and it is the one that…
TB-500 and thymosin beta-4: the fragment versus the protein Replied, post #44 · Compounds › Repair & healing peptides · 19 Jun 2025 · 23 likes TB-500 is usually the 7-residue actin-binding fragment of thymosin beta-4, not the full 43-residue protein. The two are routinely conflated in supplier documentation…
Tirzepatide in type 2 diabetes: the SURPASS programme, summarised honestly Replied, post #100 · Compounds › Tirzepatide · 2 Jun 2025 · 0 likes The five maintenance doses in the tirzepatide programme give a genuine dose-response curve, which is unusual. Most trials in this space compare one or two doses against…
Why fasting instructions for oral semaglutide are not optional advice — does this still… Replied, post #34 · Compounds › Oral incretins · 19 May 2025 · 31 likes Adding the measurement that post #33 says would settle it. Missed doses behave differently for a daily oral than for a weekly injection. With a short interval you are…
Follow-up: Documentation that appears only after payment Replied, post #59 · Sourcing › Red flags · 9 May 2025 · 0 likes I had written a reply contradicting post #57 and deleted it. Here is what survived. Where the same certificate image appears with different lot numbers, that is a…
Follow-up: Tesamorelin has an approved indication — what that changes about the evidence Replied, post #44 · Compounds › Secretagogues & GH axis · 17 Apr 2025 · 25 likes Evidence quality in the secretagogue literature is honestly weaker than in the incretin literature. Large randomised controlled trials are rare. Most evidence is…
Validating a calculator against hand arithmetic — what changed since Replied, post #15 · Data & Tools › Calculators · 13 Apr 2025 · 2 likes I had read the opposite somewhere and cannot now find where, which tells me something.
Reading an MS report that only gives you a single number Replied, post #51 · Analytics › Mass spectrometry · 12 Apr 2025 · 24 likes Resolution: "high resolution" commonly means The right answer here may simply be that it has not been measured.
A certificate with no method stated: what can you conclude? Replied, post #49 · Analytics › COA interpretation · 9 Apr 2025 · 16 likes Worth separating two things that post #47 runs together. The distinction between release testing and characterisation is one industrial documents make and retail ones…
Research-use-only labelling: what it means and what it does not — the long version Replied, post #120 · Sourcing › Regulatory · 3 Apr 2025 · 0 likes Helpful, and easy to find again, which is half of what a good reply is.
Adducts: sodium, potassium, and the peak you did not expect Replied, post #45 · Analytics › Mass spectrometry · 25 Mar 2025 · 9 likes Following, with nothing to contribute beyond having asked the same thing elsewhere.
Validating a method you did not develop — does this still hold? Replied, post #21 · Analytics › Method validation · 18 Feb 2025 · 17 likes A stability-indicating method is one demonstrated to resolve the analyte from its degradation products, usually through forced degradation. Calling a method…
What we do not know about retatrutide, listed explicitly Replied, post #81 · Compounds › Retatrutide · 3 Feb 2025 · 4 likes Post #78 and I disagree about the size of the effect, not about the direction. Nausea and vomiting were dose-related in the phase 2 work, as they are throughout this…
Protein density versus volume when you cannot eat much Replied, post #45 · Nutrition & Training › Protein & intake · 31 Jan 2025 · 0 likes Adding the measurement that post #42 says would settle it. Where intake has fallen a long way, protein is usually the first thing to fall because it is the least…
Recovery when intake is low: what to cut first Replied, post #63 · Nutrition & Training › Resistance training · 13 Jan 2025 · 0 likes I had written a reply contradicting post #61 and deleted it. Here is what survived. Reading back through the recovery threads from last year, the same three questions…
Molecular mass of semaglutide and why the figure differs between sources — does this… Replied, post #75 · Compounds › Semaglutide · 23 Dec 2024 · 31 likes Injection site does not appear to matter much for semaglutide exposure. The published comparisons of abdomen, thigh and upper arm found differences small enough to be…
The topic list is dense — is that deliberate? Replied, post #70 · Meta › Site feedback · 21 Dec 2024 · 1 like Worth separating two things that post #68 runs together. Source for the topic list figure, since it was asked for. It is in the discussion rather than the abstract,…
[2026 update] Step therapy requirements and how to satisfy them Replied, post #77 · Access › Insurance & coverage · 19 Dec 2024 · 18 likes The arithmetic on Step therapy requirements is the easy part and it is where the errors are, which is an uncomfortable combination. Show your working and someone will…
Second pass at: A field-by-field walk through a certificate of analysis Replied, post #155 · Analytics › COA interpretation · 17 Dec 2024 · 0 likes Worth separating two things that post #153 runs together. I have three months of notes on field-by-field walk through a certificate and the honest summary is that the…
SURPASS-2 and the comparator dose question that will not go away Replied, post #69 · Compounds › Tirzepatide · 2 Dec 2024 · 0 likes SURMOUNT-4 used a randomised withdrawal design: everyone titrated, then those on maintenance were randomised to continue or placebo. Continuation maintained effect;…
Revisiting: Moderation log format change Replied, post #48 · Meta › Announcements · 30 Nov 2024 · 30 likes Reading this as a member rather than staff: the change is sensible and the explanation is better than the change. Publishing the failure mode that prompted it is what…
Why quantitation is the hard part, not detection Started this topic · Analytics › Home & field testing · 8 Nov 2024 · 12 likes Why quantitation is the hard part, not detection I have a specific reason for asking rather than idle curiosity, and the context is below. Collecting what is known…
Coming back to: Research-use-only labelling: what it means and what it does not Replied, post #16 · Sourcing › Regulatory · 29 Oct 2024 · 30 likes Post #15 describes the usual case. This is about the unusual one. An indication approved for one age range does not extend to another, and paediatric extensions are…
Revisiting: How to bring a laboratory report to an appointment usefully Replied, post #17 · Clinical › Bloodwork · 8 Sep 2024 · 0 likes The second most useful thing it does is say clearly when the answer is to book the appointment. That is a description of practice, not a recommendation of it.
Second pass at: Retatrutide dose escalation in the published trials Replied, post #9 · Compounds › Retatrutide · 16 Jul 2024 · 0 likes Heart rate increased in a dose-dependent way in the phase 2 work. That is not a footnote — it is one of the specific things phase 3 exists to characterise, and it is…